ClinVar Miner

Submissions for variant NM_024675.4(PALB2):c.2850del (p.Ser951fs)

dbSNP: rs1060499824
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 4
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Ambry Genetics RCV000454187 SCV000538162 pathogenic Hereditary cancer-predisposing syndrome 2023-07-07 criteria provided, single submitter clinical testing The c.2850delC pathogenic mutation, located in coding exon 9 of the PALB2 gene, results from a deletion of one nucleotide at nucleotide position 2850, causing a translational frameshift with a predicted alternate stop codon (p.S951Lfs*11). This alteration was detected in multiple breast cancer and familial breast cancer cohorts (Damiola F et al. Breast Cancer Res. Treat., 2015 Dec;154:463-71; Sun J et al. Clin. Cancer Res., 2017 Oct;23:6113-6119; Wu Y et al. Breast Cancer Res. Treat., 2020 Feb;179:605-614). In addition to the clinical data presented in the literature, this alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. As such, this alteration is interpreted as a disease-causing mutation.
Quest Diagnostics Nichols Institute San Juan Capistrano RCV001284198 SCV001469849 pathogenic not provided 2020-08-04 criteria provided, single submitter clinical testing The variant results in a shift of the reading frame, and is therefore predicted to result in the loss of a functional protein. Found in at least one patient with expected phenotype for this gene, and not found in general population data.
Invitae RCV001383427 SCV001582568 pathogenic Familial cancer of breast 2022-10-07 criteria provided, single submitter clinical testing This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Ser951Leufs*11) in the PALB2 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in PALB2 are known to be pathogenic (PMID: 17200668, 17200671, 17200672, 24136930, 25099575). This premature translational stop signal has been observed in individual(s) with breast cancer (PMID: 28724667, 30303537). For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 402303).
Myriad Genetics, Inc. RCV001383427 SCV004189406 pathogenic Familial cancer of breast 2023-09-14 criteria provided, single submitter clinical testing This variant is considered pathogenic. This variant creates a frameshift predicted to result in premature protein truncation.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.